EA201692453A1 - Способ получения ингаляционных составов - Google Patents
Способ получения ингаляционных составовInfo
- Publication number
- EA201692453A1 EA201692453A1 EA201692453A EA201692453A EA201692453A1 EA 201692453 A1 EA201692453 A1 EA 201692453A1 EA 201692453 A EA201692453 A EA 201692453A EA 201692453 A EA201692453 A EA 201692453A EA 201692453 A1 EA201692453 A1 EA 201692453A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- obtaining
- inhalation compositions
- inhalation
- compositions
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Настоящее изобретение относится к новому способу, используемому для получения сухих порошкообразных составов для ингаляции.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR201408049 | 2014-07-09 | ||
PCT/EP2015/065599 WO2016005447A1 (en) | 2014-07-09 | 2015-07-08 | A process for preparing the inhalation formulations |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201692453A1 true EA201692453A1 (ru) | 2017-04-28 |
EA031373B1 EA031373B1 (ru) | 2018-12-28 |
Family
ID=52003034
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201692453A EA031373B1 (ru) | 2014-07-09 | 2015-07-08 | Способ получения ингаляционных составов |
Country Status (10)
Country | Link |
---|---|
US (1) | US20170266135A1 (ru) |
EP (1) | EP3166594B1 (ru) |
EA (1) | EA031373B1 (ru) |
ES (1) | ES2672383T3 (ru) |
GE (1) | GEP20196944B (ru) |
MA (1) | MA40446A (ru) |
PL (1) | PL3166594T3 (ru) |
PT (1) | PT3166594T (ru) |
TR (1) | TR201807647T4 (ru) |
WO (1) | WO2016005447A1 (ru) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7136791B2 (ja) | 2016-10-31 | 2022-09-13 | タレス オーストラリア リミテッド | 音響トランスデューサ |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6006174A (en) * | 1990-10-03 | 1999-12-21 | Interdigital Technology Coporation | Multiple impulse excitation speech encoder and decoder |
KR100912324B1 (ko) | 2001-09-14 | 2009-08-14 | 글락소 그룹 리미티드 | 호흡기 질환 치료용 펜에탄올아민 유도체 |
EP2056836A1 (en) * | 2006-08-22 | 2009-05-13 | Boehringer Ingelheim International GmbH | Powder formulations for inhalation containing enantiomerically pure beta-agonists |
US7982521B2 (en) * | 2006-10-03 | 2011-07-19 | Freescale Semiconductor, Inc. | Device and system for reducing noise induced errors |
ES2739352T3 (es) * | 2009-02-26 | 2020-01-30 | Glaxo Group Ltd | Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol |
AU2011298315B2 (en) * | 2010-08-31 | 2014-08-28 | Glaxo Group Limited | Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same |
-
2015
- 2015-07-08 EP EP15744132.0A patent/EP3166594B1/en active Active
- 2015-07-08 WO PCT/EP2015/065599 patent/WO2016005447A1/en active Application Filing
- 2015-07-08 US US15/324,194 patent/US20170266135A1/en not_active Abandoned
- 2015-07-08 ES ES15744132.0T patent/ES2672383T3/es active Active
- 2015-07-08 EA EA201692453A patent/EA031373B1/ru not_active IP Right Cessation
- 2015-07-08 TR TR2018/07647T patent/TR201807647T4/tr unknown
- 2015-07-08 PL PL15744132T patent/PL3166594T3/pl unknown
- 2015-07-08 GE GEAP201514415A patent/GEP20196944B/en unknown
- 2015-07-08 MA MA040446A patent/MA40446A/fr unknown
- 2015-07-08 PT PT157441320T patent/PT3166594T/pt unknown
Also Published As
Publication number | Publication date |
---|---|
EA031373B1 (ru) | 2018-12-28 |
EP3166594A1 (en) | 2017-05-17 |
PL3166594T3 (pl) | 2018-09-28 |
US20170266135A1 (en) | 2017-09-21 |
EP3166594B1 (en) | 2018-03-07 |
MA40446A (fr) | 2018-03-07 |
TR201807647T4 (tr) | 2018-06-21 |
PT3166594T (pt) | 2018-06-06 |
GEP20196944B (en) | 2019-02-11 |
WO2016005447A1 (en) | 2016-01-14 |
ES2672383T3 (es) | 2018-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2023008686A (es) | Polinucleotidos moduladores. | |
EA201692219A1 (ru) | Способы получения противовирусных соединений | |
MX2020001278A (es) | Sintesis de compuestos de carbamoilpiridona policiclica. | |
DK3325487T3 (da) | Formulering til bløde, anticholinerge analoger | |
DK3107548T3 (da) | Tørpulverformuleringer til inhalation | |
DK3319597T3 (da) | Sammensætninger, der omfatter antistof-duocarmycin-lægemiddelkonjugater | |
MX2016011553A (es) | Composiciones que comprenden un agente pungente. | |
EA201790983A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
CY1120759T1 (el) | Παρασκευη διγλυκοζιτη (s,s)-σεκοϊσολαρικιρεσινολης και διγλυκοζιτη (r,r)-σεκοϊσολαρικιρεσινολης | |
EA201790982A1 (ru) | Синтез копанлисиба и его дигидрохлорида | |
TR201910057T4 (tr) | Kauçuk bi̇leşi̇mleri̇ | |
MX2018000515A (es) | Compuestos fluorados de cbd, composiciones y usos de los mismos. | |
IN2014CH00840A (ru) | ||
DK3179986T3 (da) | Tørpulverformuleringer til inhalation | |
EA201690294A1 (ru) | Новые соединения и их применение для получения tau-визуализирующих агентов и tau-визуализирующих составов | |
EA201691924A1 (ru) | Фармацевтические композиции | |
IN2014CH00304A (ru) | ||
EP3102540A4 (en) | Compositions including a vacancy-engineered (ve)-zno nanocomposite, methods of making a composition, methods of using a composition | |
EA201692246A1 (ru) | Способ получения 2,6-диметилбензохинона | |
EA201691203A1 (ru) | Твёрдые формы тенофовира | |
DK3076957T3 (da) | Fremgangsmåde til fremstilling af tørpulverinhalationssammensætninger | |
EA201692453A1 (ru) | Способ получения ингаляционных составов | |
EA201692428A1 (ru) | Способ получения сухих порошкообразных составов | |
DK2915526T3 (da) | Farmaceutiske sammensætninger, der omfatter anagrelid | |
PH12017501147A1 (en) | Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG TJ TM RU |